in view of the finding that at least 70 % of patients with mild to moderate ulcerative colitis respond to rectal treatment it is suggested that this route of administration should be considered for patients experiencing side-effects after oral sulphasalazine .
C0009324
ulcerative
C0036078
sulphasalazine